Navigation Links
Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
Date:7/22/2010

n appeal, if granted, would stay delisting until a Panel ruling.  Alternatively, if at that time the Company satisfies all of the initial listing standards, with the exception of the minimum bid price, for the Nasdaq Capital Market, the Company could apply to transfer the listing of its common stock to the Nasdaq Capital Market and thereby receive an additional 180 calendar days to regain compliance with the minimum bid price requirement.

The Company will consider available options to resolve the minimum bid price deficiency and regain compliance with the Nasdaq minimum bid price requirement.  There can be no assurance that the Company will be able to regain or maintain compliance with the minimum bid price rule or other listing criteria or that an appeal, if taken, would be successful.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit http://www.poniard.com.

Forward Looking Statements

Statements made in this press release relating to future financial or business performance, conditions or strategies and other financial or business matters, including expectations and strategies regarding the Company's ability to comply with applicable listing standards, the Company's ability to transfer to the Nasdaq Capital Market and actions by Nasdaq.  These forward-looking statements are subject to certain assumptions, risks and uncertainties that could cause actual results and events to differ materially from the stateme
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
2. Poniard Pharmaceuticals Announces $6.3 Million Financing
3. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
4. Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
5. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
6. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
7. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
8. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
9. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
10. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
11. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... NAGOYA, Japan , Aug. 19, 2014 ... ASAHI INTECC (Securities Code 7747, Second Section, ... plans to develop a new, differentiated fractional flow reserve ... device intended to improve handling compared to existing FFR ... field in interventional cardiology that exceeds $250 million worldwide ...
(Date:8/18/2014)... Gamida Cell , a world leader ... that it has signed an investment and option agreement with ... " ) . According to the agreement, Novartis ... will receive 15% equity and an option to fully acquire ... of time following achievement of certain milestones connected to the ...
(Date:8/18/2014)... 2014 Reportlinker.com announces that a new ... Global Operating Room Equipment Market ... About Operating Room Equipment ... a sterile environment in a healthcare facility used ... technically advanced equipment, which ensures patient care and ...
Breaking Medicine Technology:Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 2Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 3Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 4Global Operating Room Equipment Market 2014-2018 2Global Operating Room Equipment Market 2014-2018 3Global Operating Room Equipment Market 2014-2018 4Global Operating Room Equipment Market 2014-2018 5Global Operating Room Equipment Market 2014-2018 6
... Cumberland Pharmaceuticals Inc. (Nasdaq: ... an exclusive agreement with China,s Harbin Gloria Pharmaceuticals ... ( acetylcysteine ), its injectable drug used to treat ... is used to treat pain and fever in the ...
... Ore., Feb. 28, 2012 For the first ... psoriasis—a disease of the immune system that appears ... million Americans—and psoriatic arthritis—an inflammatory joint and tendon ... Recognition on items that dermatology experts deem effective ...
Cached Medicine Technology:Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 2Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 3Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 4Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 5National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 2National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 3
(Date:8/19/2014)... The elegant bamboo floorings from BambooIndustry.com are ... in an environmentally conscious way with the company’s floorings. ... have an aluminum oxide finish to help resist wear ... areas. , Recently, the company has released its new ... These fresh items are specially made for global customers. ...
(Date:8/19/2014)... As moms and dads prepare their children ... to the normal routine of dropping their little ones off ... MSc, RD encourages them to use the opportunity to ... , Yarker explains, “Kids have small tummies, short attention ... them junk food handouts, use snack time as another daily ...
(Date:8/19/2014)... 2014 BambooIndustry.com, a well-known bamboo product manufacturer ... deckings recently. The company is excited to reveal the ... special offer for all clients. Now, every customer can get ... will last until August 30. , The company’s deckings ... the world for supreme durability. They are perfect for a ...
(Date:8/19/2014)... Dentistry in Houston, Texas, is pleased to announce it is ... or with old fillings that need replacing, will benefit from ... restore teeth. , From now on any cavities will be ... completely amalgam free. Even though amalgam fillings have been deemed ... and children over the age of six, they do contain ...
(Date:8/19/2014)... Il (PRWEB) August 20, 2014 For ... allopathic medical world that chiropractic adjustments are dangerous and ... and this is why they do not recommend chiropractic ... more educated medical doctors do refer to chiropractors because ... However a statement regarding new research has popped up ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 3Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 4
... Shannon Malloy, critically injured in a car accident, skull separating ... call her recovery a miracle. ,A car ... her spine, although her skin, spinal cord and other internal ... internal decapitation, and it left her with no control over ...
... treatments. Since it is a very painful process, continuous attempts ... for the patient. ,Now researchers say that LHRH ... stop the production of a female hormone that encourages some ... action, often mimicking the action of a naturally occurring substance. ...
... and performance of other activities but as it turns out, ... ,This is the finding of a team of ... of Alberta. ,As a part study that was ... Canada, the researchers studied 24 patients, two-thirds of whom showed ...
... Moderate drinking may lower the risk of a type of ... ,The researchers at Brigham and Women's Hospital in ... of one alcoholic beverage a day were about 30 percent ... reduced risk they found in people who drank beer, wine ...
... towards making addition of folic acid to flour or bread mandatory ... disabilities. ,After lengthy public consultations the Food Standards ... its recommendations next month after it decides whether folic acid should ... ministers accept the FSA's proposals, it will be the first time ...
... a recent report, says that health specialists were able to ... the 2005 Bali bombings, thanks to improved procedures and services ... at the Royal Darwin Hospital who treated many of the ... health nurses. ,Says Anthony Guscott from Top End ...
Cached Medicine News:Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Chronic Pain can Impair Memory and Concentration 2Health News:UK too Will Insist on Folic Acid in Bread 2Health News:UK too Will Insist on Folic Acid in Bread 3Health News:Bali Bombings Helped Improve Trauma Care 2Health News:Bali Bombings Helped Improve Trauma Care 3
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Streck-Detergent IIIA is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured specifically for use on the Abbott CELL-DYN® 1700 and 1800. The s...
Medicine Products: